The reclassification could pave the way for broader acceptance and regulatory changes, impacting medical research and market dynamics.
The post Trump administration reclassifies FDA-approved marijuana to Schedule III appeared first on Crypto Briefing.

The Trump administration has reclassified FDA-approved marijuana products to Schedule III, recognizing their medical use and lower abuse potential. The market for marijuana being rescheduled by Decem…